ImmunityBio Inc.

NASDAQ: IBRX
Share price (8/12/25): $2.47
Market cap (8/12/25): $2.335 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Selecky Christobel

Blaszyk Michael D

News Filter

Notice of Proposed Settlement of Shareholder Derivative Matters, Hearing Thereon, and Right to Appear

Reports Q2 Earnings Release Reflecting 60% Increase in Revenue in Q2 2025, With Year-To-Date Sales of $43 Million and 246% Unit Growth Since J-Code

Reports 60% Increase in Revenue in Q2 2025, With Year-To-Date Sales of $43 Million and 246% Unit Growth Since J-Code With Regulatory Updates

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports Doubled Net Revenue and 150% Unit Growth in Q1 2025, With Continued Strong Sales Momentum in First Quarter Since J-Code

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC